Standardized pressure provocation as an objective clinical marker of omalizumab response in delayed pressure urticaria: an open-label, real-life, prospective cohort.
Saved in:
| Title: | Standardized pressure provocation as an objective clinical marker of omalizumab response in delayed pressure urticaria: an open-label, real-life, prospective cohort. |
|---|---|
| Authors: | Konstantinou GN; Department of Allergy and Clinical Immunology, 424 General Military Training Hospital, Thessaloniki, Greece., Podder I; Department of Dermatology, College of Medicine and Sagore Dutta Hospital, Kolkata, West Bengal, India. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jan 29; Vol. 17, pp. 1768128. Date of Electronic Publication: 2026 Jan 29 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1768128 |
